About this trial
The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program?
Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.
Disqualifiers
Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.
Trial design
Parallel
Treatments tested in this trial
Mobile-based Acceptance and Commitment Therapy (ACT) program
Other interventionParticipants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.
Document-based Acceptance and Commitment Therapy (ACT) Program
Other interventionParticipants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.
Treatment groups
Trial outcomes
Primary outcomes
Depressive symptoms
Depressive symptoms will be measured using the Patient Health Questionnaire-9, a 9-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 9 to 36. Higher scores indicate higher levels of depressive symptoms.
Anxiety
Anxiety will be measured using the Generalized Anxiety Disorder-7, a 7-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 7 to 28. Higher scores indicate higher levels of anxiety.
Stress
Stress will be measured using the Perceived Stress Scale-10, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of stress.
Self-esteem
Self-esteem will be measured using the Rosenberg Self-Esteem Scale, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of self-esteem
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: